Role of Global Longitudinal Strain in Predicting Outcomes in Hypertrophic Cardiomyopathy

Hongyun Liu, Iraklis Pozios, Bereketeab Haileselassie, Alexandra Nowbar, Lars L. Sorensen, Susan Phillip, Dai Yin Lu, Ioannis Ventoulis, Hongchang Luo, M. Roselle Abraham, Theodore P. Abraham

Research output: Research - peer-reviewArticle

Abstract

Global longitudinal strain (GLS) is a sensitive indicator of global left ventricular function particularly in those with normal ejection fraction. We examined the potential value of GLS in predicting outcomes in hypertrophic cardiomyopathy (HC). Conventional and strain echocardiography was performed in 400 patients with HC followed for a median 3.1 years (interquartile range 1.2 to 5.6). Peak systolic strain from 3 apical views was averaged to calculate GLS. Patients were divided based on a previously published cutoff value of −16%. Additionally, we identified 4 HC subgroups based on GLS: GLS ≤ −20%, −20% < GLS ≤ −16%, −16% < GLS ≤ −10%, and GLS > −10%. The primary end point was a composite of new-onset sustained ventricular tachycardia/fibrillation, heart failure, cardiac transplantation, and all-cause death. Patients with GLS > −16% had significantly more events (17% vs 7%, p = 0.002). In the 4-group analysis, event rates increased with worsening GLS (5%, 7%, 14%, and 33%, respectively, p = 0.001). Event-free survival was significantly superior in those with GLS ≤ −16% versus GLS > −16% (p = 0.004); similarly, GLS > −10% portended a significantly worse event-free survival compared with each of the other 3 groups (p <0.01 for all pairwise comparisons). By univariate and multivariate Cox regression analysis, GLS remained significantly associated with the composite end point. GLS > −10% had 4 times the risk of events compared with GLS ≤ −16% (p = 0.006). In conclusion, echo-based GLS is independently associated with outcomes in HC. Patients with GLS > −10% have significantly higher event rates.

LanguageEnglish (US)
Pages670-675
Number of pages6
JournalAmerican Journal of Cardiology
Volume120
Issue number4
DOIs
StatePublished - Aug 15 2017

Fingerprint

Hypertrophic Cardiomyopathy
Disease-Free Survival
Ventricular Fibrillation
Heart Transplantation
Ventricular Tachycardia
Left Ventricular Function
Echocardiography
Cause of Death
Heart Failure
Regression Analysis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Liu, H., Pozios, I., Haileselassie, B., Nowbar, A., Sorensen, L. L., Phillip, S., ... Abraham, T. P. (2017). Role of Global Longitudinal Strain in Predicting Outcomes in Hypertrophic Cardiomyopathy. American Journal of Cardiology, 120(4), 670-675. DOI: 10.1016/j.amjcard.2017.05.039

Role of Global Longitudinal Strain in Predicting Outcomes in Hypertrophic Cardiomyopathy. / Liu, Hongyun; Pozios, Iraklis; Haileselassie, Bereketeab; Nowbar, Alexandra; Sorensen, Lars L.; Phillip, Susan; Lu, Dai Yin; Ventoulis, Ioannis; Luo, Hongchang; Abraham, M. Roselle; Abraham, Theodore P.

In: American Journal of Cardiology, Vol. 120, No. 4, 15.08.2017, p. 670-675.

Research output: Research - peer-reviewArticle

Liu, H, Pozios, I, Haileselassie, B, Nowbar, A, Sorensen, LL, Phillip, S, Lu, DY, Ventoulis, I, Luo, H, Abraham, MR & Abraham, TP 2017, 'Role of Global Longitudinal Strain in Predicting Outcomes in Hypertrophic Cardiomyopathy' American Journal of Cardiology, vol 120, no. 4, pp. 670-675. DOI: 10.1016/j.amjcard.2017.05.039
Liu H, Pozios I, Haileselassie B, Nowbar A, Sorensen LL, Phillip S et al. Role of Global Longitudinal Strain in Predicting Outcomes in Hypertrophic Cardiomyopathy. American Journal of Cardiology. 2017 Aug 15;120(4):670-675. Available from, DOI: 10.1016/j.amjcard.2017.05.039
Liu, Hongyun ; Pozios, Iraklis ; Haileselassie, Bereketeab ; Nowbar, Alexandra ; Sorensen, Lars L. ; Phillip, Susan ; Lu, Dai Yin ; Ventoulis, Ioannis ; Luo, Hongchang ; Abraham, M. Roselle ; Abraham, Theodore P./ Role of Global Longitudinal Strain in Predicting Outcomes in Hypertrophic Cardiomyopathy. In: American Journal of Cardiology. 2017 ; Vol. 120, No. 4. pp. 670-675
@article{d567ed3fa04d4a2fa0f5a2bc00a9d790,
title = "Role of Global Longitudinal Strain in Predicting Outcomes in Hypertrophic Cardiomyopathy",
abstract = "Global longitudinal strain (GLS) is a sensitive indicator of global left ventricular function particularly in those with normal ejection fraction. We examined the potential value of GLS in predicting outcomes in hypertrophic cardiomyopathy (HC). Conventional and strain echocardiography was performed in 400 patients with HC followed for a median 3.1 years (interquartile range 1.2 to 5.6). Peak systolic strain from 3 apical views was averaged to calculate GLS. Patients were divided based on a previously published cutoff value of −16%. Additionally, we identified 4 HC subgroups based on GLS: GLS ≤ −20%, −20% < GLS ≤ −16%, −16% < GLS ≤ −10%, and GLS > −10%. The primary end point was a composite of new-onset sustained ventricular tachycardia/fibrillation, heart failure, cardiac transplantation, and all-cause death. Patients with GLS > −16% had significantly more events (17% vs 7%, p = 0.002). In the 4-group analysis, event rates increased with worsening GLS (5%, 7%, 14%, and 33%, respectively, p = 0.001). Event-free survival was significantly superior in those with GLS ≤ −16% versus GLS > −16% (p = 0.004); similarly, GLS > −10% portended a significantly worse event-free survival compared with each of the other 3 groups (p <0.01 for all pairwise comparisons). By univariate and multivariate Cox regression analysis, GLS remained significantly associated with the composite end point. GLS > −10% had 4 times the risk of events compared with GLS ≤ −16% (p = 0.006). In conclusion, echo-based GLS is independently associated with outcomes in HC. Patients with GLS > −10% have significantly higher event rates.",
author = "Hongyun Liu and Iraklis Pozios and Bereketeab Haileselassie and Alexandra Nowbar and Sorensen, {Lars L.} and Susan Phillip and Lu, {Dai Yin} and Ioannis Ventoulis and Hongchang Luo and Abraham, {M. Roselle} and Abraham, {Theodore P.}",
year = "2017",
month = "8",
doi = "10.1016/j.amjcard.2017.05.039",
volume = "120",
pages = "670--675",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Role of Global Longitudinal Strain in Predicting Outcomes in Hypertrophic Cardiomyopathy

AU - Liu,Hongyun

AU - Pozios,Iraklis

AU - Haileselassie,Bereketeab

AU - Nowbar,Alexandra

AU - Sorensen,Lars L.

AU - Phillip,Susan

AU - Lu,Dai Yin

AU - Ventoulis,Ioannis

AU - Luo,Hongchang

AU - Abraham,M. Roselle

AU - Abraham,Theodore P.

PY - 2017/8/15

Y1 - 2017/8/15

N2 - Global longitudinal strain (GLS) is a sensitive indicator of global left ventricular function particularly in those with normal ejection fraction. We examined the potential value of GLS in predicting outcomes in hypertrophic cardiomyopathy (HC). Conventional and strain echocardiography was performed in 400 patients with HC followed for a median 3.1 years (interquartile range 1.2 to 5.6). Peak systolic strain from 3 apical views was averaged to calculate GLS. Patients were divided based on a previously published cutoff value of −16%. Additionally, we identified 4 HC subgroups based on GLS: GLS ≤ −20%, −20% < GLS ≤ −16%, −16% < GLS ≤ −10%, and GLS > −10%. The primary end point was a composite of new-onset sustained ventricular tachycardia/fibrillation, heart failure, cardiac transplantation, and all-cause death. Patients with GLS > −16% had significantly more events (17% vs 7%, p = 0.002). In the 4-group analysis, event rates increased with worsening GLS (5%, 7%, 14%, and 33%, respectively, p = 0.001). Event-free survival was significantly superior in those with GLS ≤ −16% versus GLS > −16% (p = 0.004); similarly, GLS > −10% portended a significantly worse event-free survival compared with each of the other 3 groups (p <0.01 for all pairwise comparisons). By univariate and multivariate Cox regression analysis, GLS remained significantly associated with the composite end point. GLS > −10% had 4 times the risk of events compared with GLS ≤ −16% (p = 0.006). In conclusion, echo-based GLS is independently associated with outcomes in HC. Patients with GLS > −10% have significantly higher event rates.

AB - Global longitudinal strain (GLS) is a sensitive indicator of global left ventricular function particularly in those with normal ejection fraction. We examined the potential value of GLS in predicting outcomes in hypertrophic cardiomyopathy (HC). Conventional and strain echocardiography was performed in 400 patients with HC followed for a median 3.1 years (interquartile range 1.2 to 5.6). Peak systolic strain from 3 apical views was averaged to calculate GLS. Patients were divided based on a previously published cutoff value of −16%. Additionally, we identified 4 HC subgroups based on GLS: GLS ≤ −20%, −20% < GLS ≤ −16%, −16% < GLS ≤ −10%, and GLS > −10%. The primary end point was a composite of new-onset sustained ventricular tachycardia/fibrillation, heart failure, cardiac transplantation, and all-cause death. Patients with GLS > −16% had significantly more events (17% vs 7%, p = 0.002). In the 4-group analysis, event rates increased with worsening GLS (5%, 7%, 14%, and 33%, respectively, p = 0.001). Event-free survival was significantly superior in those with GLS ≤ −16% versus GLS > −16% (p = 0.004); similarly, GLS > −10% portended a significantly worse event-free survival compared with each of the other 3 groups (p <0.01 for all pairwise comparisons). By univariate and multivariate Cox regression analysis, GLS remained significantly associated with the composite end point. GLS > −10% had 4 times the risk of events compared with GLS ≤ −16% (p = 0.006). In conclusion, echo-based GLS is independently associated with outcomes in HC. Patients with GLS > −10% have significantly higher event rates.

UR - http://www.scopus.com/inward/record.url?scp=85021711189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021711189&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2017.05.039

DO - 10.1016/j.amjcard.2017.05.039

M3 - Article

VL - 120

SP - 670

EP - 675

JO - American Journal of Cardiology

T2 - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 4

ER -